Ret Proto-Oncogene Antikörper (AA 702-848)
Kurzübersicht für Ret Proto-Oncogene Antikörper (AA 702-848) (ABIN6940506)
Target
Alle Ret Proto-Oncogene (RET) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 702-848
-
Verwendungszweck
- RET Proto-oncogene Antibody
-
Spezifität
- The Ret proto-oncogene is structurally related to the growing family of tyrosine kinase transmembrane receptors and is involved in GDNF signaling. RET expression is reported in several regions of the central nervous system, in the developing cranial nerve ganglia and a subset of cells within dorsal root ganglia, in motor neurons in the spinal cord and hindbrain, in neuro-retina and the growing tips of the renal collecting ducts in developing kidney.Alterations in RETgene are associated with diseases including papillary thyroid carcinoma, multiple endocrine neoplasia (type 2A and 2B), familial medullary thyroid carcinoma, and a congenital developmental disorder known as Hirschsprung's disease.
-
Aufreinigung
- 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- Recombinant fragment (around aa 702-848) of human RET protein (exact sequence is proprietary)
-
Isotyp
- IgG2b, kappa
-
-
-
-
Applikationshinweise
-
Positive Control: Breast, Prostate or Colon Carcinoma.
Known Application: ELISA (For coating, order Ab without BSA)Optimal dilution for a specific application should be determined.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 200 μg/mL
-
Buffer
- Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Haltbarkeit
- 24 months
-
-
- Ret Proto-Oncogene (RET)
-
Andere Bezeichnung
- RET
-
Hintergrund
-
Cadherin family member 12 (CDHF12), Cadherin related family member 16 (CDHR16), ELKS, HSCR1, Hydroxyaryl protein kinase, MEN2A, MEN2B, MTC1, Multiple endocrine neoplasia and medullary thyroid carcinoma 1, Oncogene RET, Proto-oncogene c-Ret, Proto-oncogene tyrosine-protein kinase receptor ret, PTC, RET, RET ELE1, RET51, RET9
Breast, Prostate or Colon Carcinoma.
-
Molekulargewicht
- 150kDa (precursor), 170kDa (Mature)
-
Gen-ID
- 5979, 350321
-
UniProt
- P07949
-
Pathways
- RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Target
-